Your read is correct with regards to most markets in general whereas mine refers to a possible future specific case. Again, data is too initial to answer the big question of the role of interferon and/or ribavirin in the future treatment paradigm, but I think that this is where the industry is pushing to and my feeling is they'll get there in time.
Market Data 
Markets 
AI
